The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Biomarker development in the precision medicine era: lung cancer as a case study
Open accessAbstract
Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable 'omics'-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is still stymied by low statistical power and poor reproducibility of results. This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the future of precision medicine research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
Long Noncoding RNAs in Cancer Pathways
Schmitt, A. M., & Chang, H. Y. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.010 · Cited by 2,992
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Wild, C. P. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0456 · Cited by 2,562
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
PD-L1 expression as a predictive biomarker in cancer immunotherapy
Patel, S. P., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0983 · Cited by 2,291
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Similarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Handelsman, J., Rondon, M. R., Brady, S. F., Clardy, J., & Goodman, R. M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90108-9 · Cited by 1,998
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Metabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Emerging applications of metabolomics in drug discovery and precision medicine
Wishart, D. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.32 · Cited by 1,488
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
REporting recommendations for tumour MARKer prognostic studies (REMARK).
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602678 · Cited by 1,394
Diversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,298
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K. L., Maher, C. A., Fulton, R., Fulton, L., Wallis, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,146
Commercialization of microfluidic point-of-care diagnostic devices
Chin, C. D., Linder, V., & Sia, S. K. (2012) · Lab on a Chip · doi:10.1039/c2lc21204h · Cited by 1,124
Alberg, A. J., & Samet, J. M. (2010) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4160-4710-0.00046-8 · Cited by 1,060
Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations
Elmore, J. G., Barton, M. B., Moceri, V. M., Polk, S., Arena, P. J., & Fletcher, S. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381601 · Cited by 1,053
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
Lê Cao, K.-A., Boitard, S., & Besse, P. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-253 · Cited by 1,007
Elliott, P., Peakman, T. C., & Biobank, O. B. O. U. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym276 · Cited by 991
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
Pagano, M., Gauvreau, K., & Mattie, H. (2022) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429340512 · Cited by 926
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 864
Understanding multicellular function and disease with human tissue-specific networks
Greene, C. S., Krishnan, A., Wong, A. K., Ricciotti, E., Zelaya, R. A., Himmelstein, D. S., Zhang, R., Hartmann, B. M., Zaslavsky, E., Sealfon, S. C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3259 · Cited by 832
Alberg, A. J., Brock, M. V., & Samet, J. M. (2016) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4557-3383-5.00052-x · Cited by 781
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Reporting Recommendations for Tumor Marker Prognostic Studies
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0454 · Cited by 779
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
the eMERGE Team, McCarty, C. A., Chisholm, R. L., Chute, C. G., Kullo, I. J., Jarvik, G. P., Larson, E. B., Li, R., Masys, D. R., Ritchie, M. D., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-13 · Cited by 699
From RNA-seq reads to differential expression results
Oshlack, A., Robinson, M. D., & Young, M. D. (2010) · Genome Biology · doi:10.1186/gb-2010-11-12-220 · Cited by 698
Dynamic modularity in protein interaction networks predicts breast cancer outcome
Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q., & Wrana, J. L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1522 · Cited by 697
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14068-8 · Cited by 602
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578
Florkowski, C. M. (2008) · PubMed · Cited by 575
REporting recommendations for tumor MARKer prognostic studies (REMARK)
for the Statistics Subcommittee of the NCI—EORTC Working Group on Cancer Diagnostics (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0252 · Cited by 561
Mutational Activation of the K-ras Oncogene
Rodenhuis, S., van de Wetering, M. L., Mooi, W. J., Evers, S. G., van Zandwijk, N., & Bos, J. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171504 · Cited by 536
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498
Lung carcinogenesis by tobacco smoke
Hecht, S. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27816 · Cited by 480
Microbiome and Anticancer Immunosurveillance
Zitvogel, L., Ayyoub, M., Routy, B., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.001 · Cited by 478
Medicine, N. L. O. (2008) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280801989377 · Cited by 468
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.001 · Cited by 462
The lung microbiome in moderate and severe chronic obstructive pulmonary disease
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C., & Isaacson, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047305 · Cited by 437
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Füzéry, A. K., Levin, J., Chan, M. M., & Chan, D. W. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-13 · Cited by 428
Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
Schalper, K. A., Brown, J., Carvajal-Hausdorf, D., McLaughlin, J., Velcheti, V., Syrigos, K. N., Herbst, R. S., & Rimm, D. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju435 · Cited by 417
A Risk Model for Prediction of Lung Cancer
Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., & Etzel, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk153 · Cited by 417
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-51 · Cited by 372
Ziegel, E. R., Pagano, M., & Gauvreau, K. (1994) · Technometrics · doi:10.2307/1269984 · Cited by 357
Remarks by the President in State of the Union Address
연구원자료 (2011) · Cited by 327
Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Kobayashi, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206288 · Cited by 317
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Butkiewicz, D., Rusin, M., Enewold, L., Shields, P. G., Chorazy, M., & Harris, C. C. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.593 · Cited by 314
Self-citationREporting recommendations for tumour MARKer prognostic studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.032 · Cited by 311
Kerr, K. M., Bubendorf, L., Edelman, M. J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S., Felip, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu145 · Cited by 298
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
Yuan, Y., Van Allen, E. M., Omberg, L., Wagle, N., Amin-Mansour, A., Sokolov, A., Byers, L. A., Xu, Y., Hess, K. R., Diao, L., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2940 · Cited by 280
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5516 · Cited by 278
Storage conditions of intestinal microbiota matter in metagenomic analysis
Cardona, S., Eck, A., Cassellas, M., Gallart, M., Alastrue, C., Dore, J., Azpiroz, F., Roca, J., Guarner, F., & Manichanh, C. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-158 · Cited by 273
Passing Messages between Biological Networks to Refine Predicted Interactions
Glass, K., Huttenhower, C., Quackenbush, J., & Yuan, G.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064832 · Cited by 266
Lee, E.-S., Son, D.-S., Kim, S.-H., Lee, J., Jo, J., Han, J., Kim, H., Lee, H. J., Choi, H. Y., Jung, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4937 · Cited by 265
EPIC-Norfolk: Study design and characteristics of the cohort
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · UEA Digital Repository (University of East Anglia) · Cited by 261
Smoking, p53 Mutation, and Lung Cancer
Gibbons, D. L., Byers, L. A., & Kurie, J. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0539 · Cited by 255
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
Jamal-Hanjani, M., Hackshaw, A., Ngai, Y., Shaw, J., Dive, C., Quezada, S., Middleton, G., de Bruin, E., Le Quesne, J., Shafi, S., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001906 · Cited by 247
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
Li, Y., Sheu, C.-C., Ye, Y., de Andrade, M., Wang, L., Chang, S.-C., Aubry, M. C., Aakre, J. A., Allen, M. S., Chen, F., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70042-5 · Cited by 246
Self-citationStadtländer, C. T. K.-H. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.05.004 · Cited by 245
Cigarette smoke impairs airway epithelial barrier function and cell–cell contact recovery
Heijink, I. H., Brandenburg, S. M., Postma, D. S., & van Oosterhout, A. J. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00193810 · Cited by 245
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer
Shukuya, T., & Carbone, D. P. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.02.015 · Cited by 245
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
Carrola, J., Rocha, C. M., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., Bernardo, J., Gomes, A., Sousa, V., Carvalho, L., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr100899x · Cited by 226
The potential role of lung microbiota in lung cancer attributed to household coal burning exposures
Hosgood, H. D., Sapkota, A. R., Rothman, N., Rohan, T., Hu, W., Xu, J., Vermeulen, R., He, X., White, J. R., Wu, G., et al. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21878 · Cited by 215
Luo, J., Shen, L., & Zheng, D. (2014) · Scientific Reports · doi:10.1038/srep06269 · Cited by 212
Annual number of lung cancer deaths potentially avertable by screening in the United States
Ma, J., Ward, E. M., Smith, R., & Jemal, A. (2013) · Cancer · doi:10.1002/cncr.27813 · Cited by 207
Saito, M., Schetter, A. J., Mollerup, S., Kohno, T., Skaug, V., Bowman, E. D., Mathé, E. A., Takenoshita, S., Yokota, J., Haugen, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2961 · Cited by 197
Self-citationMathé, E. A., Patterson, A. D., Haznadar, M., Manna, S. K., Krausz, K. W., Bowman, E. D., Shields, P. G., Idle, J. R., Smith, P. B., Anami, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0109 · Cited by 195
Self-citationProcessing faecal samples: a step forward for standards in microbial community analysis
Santiago, A., Panda, S., Mengels, G., Martinez, X., Azpiroz, F., Dore, J., Guarner, F., & Manichanh, C. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-112 · Cited by 191
Zhukov, T. A., Johanson, R. A., Cantor, A. B., Clark, R. A., & Tockman, M. S. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00082-5 · Cited by 184
Patz, E. F., Greco, E., Gatsonis, C., Pinsky, P., Kramer, B. S., & Aberle, D. R. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00621-x · Cited by 184
Dobbin, K. K., Beer, D. G., Meyerson, M., Yeatman, T. J., Gerald, W. L., Jacobson, J. W., Conley, B., Buetow, K. H., Heiskanen, M., Simon, R. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.565.11.2 · Cited by 179
Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
Korpanty, G. J., Graham, D. M., Vincent, M. D., & Leighl, N. B. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00204 · Cited by 175
An Expanded Risk Prediction Model for Lung Cancer
Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., & Hong, W. K. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0060 · Cited by 160
Pinsky, P. F., & Berg, C. D. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012010 · Cited by 156
Human Pathogens Abundant in the Bacterial Metagenome of Cigarettes
Sapkota, A. R., Berger, S., & Vogel, T. M. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901201 · Cited by 154
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
Polley, M.-Y. C., Freidlin, B., Korn, E. L., Conley, B. A., Abrams, J. S., & McShane, L. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt282 · Cited by 151
Epigenetic biomarkers in lung cancer
Liloglou, T., Bediaga, N. G., Brown, B. R. B., Field, J. K., & Davies, M. P. A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.018 · Cited by 148
Reporting recommendations for tumor marker prognostic studies (remark).
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2006) · PubMed · Cited by 148
Liquet, B., Cao, K. L., Hocini, H., & Thiébaut, R. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-325 · Cited by 132
Robles, A. I., Arai, E., Mathé, E. A., Okayama, H., Schetter, A. J., Brown, D. W., Petersen, D. W., Bowman, E. D., Noro, R., Welsh, J. A., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000560 · Cited by 128
Self-citationMcRonald, F. E., Yadegarfar, G., Baldwin, D., Devaraj, A., Brain, K. E., Eisen, T. G., Holemans, J. A., Ledson, M. J., Screaton, N. J., Rintoul, R. C., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0206 · Cited by 127
A Brave New World: The Lung Microbiota in an Era of Change
Segal, L. N., & Blaser, M. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-189mg · Cited by 124
Li, L., Wei, Y., To, C., Zhu, C., Tong, J., Pham, N., Taylor, P. P., Ignatchenko, V., Ignatchenko, A., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6469 · Cited by 118
Serum Concentrations of Cytokines and Lung Cancer Survival in African Americans and Caucasians
Enewold, L., Mechanic, L. E., Bowman, E. D., Zheng, Y., Yu, Z., Trivers, G., Alberg, A. J., & Harris, C. C. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0705 · Cited by 108
Self-citationKim, Y. J., Sertamo, K., Pierrard, M.-A., Mesmin, C., Kim, S.-Y., Schlesser, M., Berchem, G., & Domon, B. (2015) · Journal of Proteome Research · doi:10.1021/pr5010828 · Cited by 106
Castle, A. L. (2006) · Briefings in Bioinformatics · doi:10.1093/bib/bbl008 · Cited by 102
Rocha, C., Barros, A. S., Goodfellow, B. J., Carreira, I. M., Gomes, A., de Sousa, V. M. L., Bernardo, J., Carvalho, L., Gil, A. M., & Duarte, I. F. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu226 · Cited by 100
Can clinically localized prostate cancer be managed conservatively?
Klotz, L. H. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0292 · Cited by 98
Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma
Wikoff, W. R., Grapov, D., Fahrmann, J. F., DeFelice, B. C., Rom, W. N., Pass, H. I., Kim, K., Nguyen, U. T., Taylor, S. L., Gandara, D. R., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0329 · Cited by 94
Atkins, M. B., & Larkin, J. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv414 · Cited by 92
Lung Cancer and Personalized Medicine
Ahmad, A., & Gadgeel, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24223-1 · Cited by 91
Miyamoto, S., Taylor, S. L., Barupal, D. K., Taguchi, A., Wohlgemuth, G., Wikoff, W. R., Yoneda, K. Y., Gandara, D. R., Hanash, S., Kim, K., et al. (2015) · Metabolites · doi:10.3390/metabo5020192 · Cited by 85
Barrera, L., Montes-Servín, E., Barrera, A., Ramírez-Tirado, L. A., Salinas-Parra, F., Bañales-Mendez, J. L., Sandoval-Ríos, M., & Arrieta, O. G. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu549 · Cited by 79
A High-Dimensional, Deep-Sequencing Study of Lung Adenocarcinoma in Female Never-Smokers
Kim, S. C., Jung, Y., Park, J., Cho, S., Seo, C., Kim, J., Kim, P., Park, J., Seo, J., Kim, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055596 · Cited by 79
A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis
Kadara, H. N., Behrens, C., Yuan, P., Solis, L. M., Liu, D., Gu, X., Minna, J. D., Lee, J. J., Kim, E., Hong, W.-K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2703 · Cited by 75
Alifano, M., Falcoz, P., Seegers, V., Roche, N., Schussler, O., Younes, M., Antonacci, F., Forgez, P., Dechartres, A., Massard, G., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.07.021 · Cited by 74
Mechanic, L. E., Bowman, E. D., Welsh, J. A., Ma, K., Hagiwara, N., Enewold, L., Shields, P. G., Burdette, L. A., Chanock, S. J., & Harris, C. C. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0790 · Cited by 73
Self-citationNetwork‐based drugs and biomarkers
Erler, J. T., & Linding, R. (2009) · The Journal of Pathology · doi:10.1002/path.2646 · Cited by 72
Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer
Fahrmann, J. F., Kim, K., DeFelice, B. C., Taylor, S. L., Gandara, D. R., Yoneda, K. Y., Cooke, D. T., Fiehn, O., Kelly, K. L., & Miyamoto, S. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0427 · Cited by 64
Ryan, B. M., Robles, A. I., McClary, A. C., Haznadar, M., Bowman, E. D., Pine, S. R., Brown, D. W., Ma, K., Shiraishi, K., Kohno, T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2101 · Cited by 62
Self-citationPolymorphisms in XPD and TP53 and mutation in human lung cancer
Mechanic, L. E., Marrogi, A. J., Welsh, J. A., Bowman, E. D., Khan, M. A., Enewold, L., Zheng, Y.-L., Chanock, S., Shields, P. G., & Harris, C. C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh344 · Cited by 62
Self-citationShinjo, K., Okamoto, Y., An, B., Yokoyama, T., Takeuchi, I., Fujii, M., Osada, H., Usami, N., Hasegawa, Y., Ito, H. M., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs154 · Cited by 62
Vallée, A., Loupp, A.-G. L., & Denis, M. G. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.11.014 · Cited by 59
Akagi, I., Okayama, H., Schetter, A. J., Robles, A. I., Kohno, T., Bowman, E. D., Kazandjian, D. G., Welsh, J. A., Oue, N., Saito, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0031 · Cited by 59
Self-citationRyan, B. M., Pine, S. R., Chaturvedi, A. K., Caporaso, N. E., & Harris, C. C. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000278 · Cited by 58
Self-citationElevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer
Hong, S., Kang, Y. A., Cho, B. C., & Kim, D. J. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.111 · Cited by 57
FDA Perspective on Companion Diagnostics: An Evolving Paradigm
Mansfield, E. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1954 · Cited by 52
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
Ahmad, A., & Gadgeel, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2 · Cited by 52
Lung Cancer Survival and Functional Polymorphisms in MBL2, an Innate-Immunity Gene
Pine, S. R., Mechanic, L. E., Ambs, S., Bowman, E. D., Chanock, S. J., Loffredo, C. A., Shields, P. G., & Harris, C. C. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm128 · Cited by 49
Self-citationPignatti, F., Ehmann, F., Hemmings, R., Jönsson, B., Nuebling, M., Papaluca‐Amati, M., Posch, M., & Rasi, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1571 · Cited by 46
Pulmonary nodules and CT screening: the past, present and future
Ruparel, M., Quaife, S. L., Navani, N., Wardle, J., Janes, S. M., & Baldwin, D. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-208107 · Cited by 41
Zhang, L., Gao, G., Li, X., Ren, S., Li, A., Xu, J., Zhang, J., & Zhou, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048350 · Cited by 40
Advances in Molecular Biology of Lung Disease
Rooney, C., & Sethi, T. (2015) · CHEST Journal · doi:10.1378/chest.14-2663 · Cited by 32
Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer
Kumar, M., Ernani, V., & Owonikoko, T. K. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.009 · Cited by 31
Liu, C.-Y., Stücker, I., Chen, C., Goodman, G. E., McHugh, M. K., D'amelio, A. M., Etzel, C. J., Li, S., Lin, X., & Christiani, D. C. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0021 · Cited by 30
The Early Detection Research Network: 10-Year Outlook
Srivastava, S. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.184697 · Cited by 30
Okayama, H., Schetter, A. J., Ishigame, T., Robles, A. I., Kohno, T., Yokota, J., Takenoshita, S., & Harris, C. C. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0182 · Cited by 25
Self-citationNon-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design
Dimou, A., & Papadimitrakopoulou, V. A. (2014) · Journal of Personalized Medicine · doi:10.3390/jpm4030386 · Cited by 15
Song, G., Liu, Y., Wang, Y., Ren, G.-J., Guo, S., Ren, J., Zhang, L., & Li, Z. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.11.010 · Cited by 15
Khariwala, S. S., Carmella, S. G., Stepanov, I. S., et al. (2015) · The Laryngoscope · doi:10.1002/lary.25290 · Cited by 15
Chromatin Immunoprecipitation (ChIP) Methodology and Readouts
Massie, C. E., & Mills, I. G. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-575-0_7 · Cited by 13
Rothman, K. J., Huybrechts, K. F., & Murray, E. J. (2024) · doi:10.1093/oso/9780197751541.001.0001 · Cited by 12
Biomarkers of Tobacco Smoke Exposure in Racial/Ethnic Groups at High Risk for Lung Cancer
Fagan, P., Moolchan, E. T., Pokhrel, P., Herzog, T. A., Cassel, K., Pagano, I., Franke, A. A., Kaholokula, J. K., Sy, A. U., Alexander, L. A., et al. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302492 · Cited by 11
Quantification of concentration and assessment of EGFR mutation in circulating DNA
Mazurek, A. M., Pierzyna-Świtała, M., Giglok, M., Dworzecka, U., Suwiński, R., & Małusecka, E. (2015) · Cancer Biomarkers · doi:10.3233/cbm-150471 · Cited by 3
Cited by
Sex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
A review on graphene-based nanocomposites for electrochemical and fluorescent biosensors
Krishnan, S. K., Singh, E., Singh, P., Meyyappan, M., & Nalwa, H. S. (2019) · RSC Advances · doi:10.1039/c8ra09577a · Cited by 785
Ultrasensitive detection of miRNA with an antimonene-based surface plasmon resonance sensor
Xue, T., Liang, W., Li, Y., Sun, Y., Xiang, Y., Zhang, Y., Dai, Z., Duo, Y., Wu, L., Qi, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07947-8 · Cited by 764
Smart textiles for personalized healthcare
Libanori, A., Chen, G., Zhao, X., Zhou, Y., & Chen, J. (2022) · Nature Electronics · doi:10.1038/s41928-022-00723-z · Cited by 739
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Metadata
- Authors
- Vargas, A. J., & Harris, C. C.
- Venue
- Nature Reviews Cancer
- Published
- 2016-07-08
- Volume
- 16
- Issue
- 8
- Pages
- 525-537
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2468543693
- Cited by
- 556
- References
- 154
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.